Wolverine Asset Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Wolverine Asset Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306K	Buy	170,698 +15,829	+10%	+$30.7K	﹤0.01%	1024
2025 Q4	$146K	Buy	154,869 +84,520	+120%	+$47.6K	﹤0.01%	1148
2025 Q3	$21.1K	Hold	70,349	–	–	﹤0.01%	1293
2025 Q2	$18.5K	Hold	70,349	–	–	﹤0.01%	1322
2025 Q1	$2.67K	Hold	70,349	–	–	﹤0.01%	1415
2024 Q4	$12.7K	Hold	70,349	–	–	﹤0.01%	1334
2024 Q3	$9.85K	Hold	70,349	–	–	﹤0.01%	1328
2024 Q2	$7.18K	Hold	70,349	–	–	﹤0.01%	1365
2024 Q1	$12.8K	Hold	70,349	–	–	﹤0.01%	1260
2023 Q4	$23.2K	Buy	+70,349	New	+$31.4K	﹤0.01%	1299

Other funds holding RVMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Wolverine Asset Management's RVMDW Position: Q1 2026 in Review

Wolverine Asset Management increased its Revolution Medicines Inc Warrant (RVMDW) stake by 10% in Q1 2026, buying an estimated $30.7K and bringing the position to 170,698 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Wolverine Asset Management first reported a position in RVMDW in Q4 2023 and has held it in 10 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

Wolverine Asset Management held 170,698 shares of Revolution Medicines Inc Warrant worth $306K as of Q1 2026.
Wolverine Asset Management bought 15,829 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $30.7K.
Revolution Medicines Inc Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1024 holding.
Wolverine Asset Management first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 10 quarters since.
23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.